Clinical Trial Update: Study of Breakthrough Cancer Pain: Assessment of Fentanyl Buccal Tablets Titration and Treatment in Opioid-Tolerant Patients [Phase 4]

View source ↗

Summary

Phase 4 study evaluating titration and treatment of breakthrough cancer pain with fentanyl buccal tablets in opioid-tolerant patients; the trial was terminated …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Drugs mentioned

• Fentanyl Buccal Tablet (fentanyl buccal tablet)

Snippet

Sponsor: Cephalon | Conditions: Cancer Pain, Breakthrough Pain | Phase 4 | Status: TERMINATED | Results posted: 2012-09-20